Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Tuesday, December 17, 2024
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Venture Capital
SwiftConnect Raises $37 Million of Financing in Series B Round
Life Sciences Times
-
November 14, 2024
0
Venture Capital
SAI MedPartners Expands Strategic Service Offering Through Acquisition of IDEA Pharma
Life Sciences Times
-
November 14, 2024
0
Medtech
Predictive Heart Monitoring Startup, GPx, Secures New Investment From NEC X; Joins Elev X! Boost Venture Studio Program
Life Sciences Times
-
November 13, 2024
0
Venture Capital
Metsera Secures $215 Million Series B Financing to Further Accelerate Portfolio
Life Sciences Times
-
November 13, 2024
0
Medtech
QPS Launches New Leukopak and Cell Therapy Products Facility
Life Sciences Times
-
November 13, 2024
0
People on the Move
GenEdit Appoints Dr. J. Rodrigo Mora as Chief Scientific Officer to Expand Its NanoGalaxy® Genetic Medicine Platform into Immunology
Life Sciences Times
-
November 13, 2024
0
Venture Capital
TRexBio Announces $84 Million Series B Financing to Advance Pipeline of First-in-Class Immunology Programs into Clinical Development
Life Sciences Times
-
November 13, 2024
0
People on the Move
Lumicell’s Board of Directors Appoints Howard Hechler as Chief Executive Officer
Life Sciences Times
-
November 13, 2024
0
People on the Move
Crossroads Treatment Centers Appoints Nick Sulaiman as President and Chief Operations Officer
Life Sciences Times
-
November 12, 2024
0
People on the Move
Grenova Announces Katherine Marrs as New CEO to Drive Innovation and Growth
Life Sciences Times
-
November 12, 2024
0
1
...
6
7
8
...
572
Page 7 of 572
Most Popular
VectorY Strengthens Leadership Team with Appointment of Jim Scibetta as New CEO
December 16, 2024
MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas
December 16, 2024
Pleno, Inc. Appoints Dr. Vik Vaz, M.D. as Chief Executive Officer & President to Drive Commercial Growth After Closing $25M Series B Funding
December 12, 2024
Turn Therapeutics Secures $75 Million Investment Commitment Tied to Public Listing
December 12, 2024
Load more
Recent Comments
Recent Comments